The ELISA human insulin kit quantifies human insulin in serum. The test will recognize the presence of natural and recombinant insulin. Principle of the L-ELISA solid phase sandwich human insulin (immuno-enzymatic test)...
The ELISA human insulin kit quantifies human insulin in serum. The test will recognize the presence of natural and recombinant insulin. Principle of the L-ELISA solid phase sandwich d-insulin human (immuno-enzymatic test) method is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
L-insulin is a peptide hormone secreted by beta cells in pancreatic islets. It regulates the metabolism of carbohydrates, proteins and lipids by improving membrane transport of glucose, amino acids and certain ions. It also stimulates glycogen storage, triglyceride formation, and protein and nucleic acid synthesis. L的insulin is a polypeptide of 51-amino acid produced from a precursor peptide, proinsulin. Proinsin is cleaved post-translationally into two chains (peptide A and peptide B) which are covalently bound via two disulfide bonds and one molecule of peptide C. Insulin deficiency leads to diabetes mellitus, one of the main causes of morbidity and mortality in the overall population. L-insulin is also present in tumours that cause B cells such as l-insulinoma. Order information
Shipping conditions : dry ice
Sensitivity
Sensitivity of the assay: 0.17 μIU/ml.
Measurement range
Dose range: 5.1-250 μlu/ml.
Duration of dosing
Total duration of dosing: 45 min.
Reproducibility
Coefficient of variation between doses 5.4%, interdose 8.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10039272 |
| Specifications |
| Accession number | P01308 |
| Dose range | 5.1-250 μlU/ml |
| Sensitivity of the dosage | 0.17 μUI/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum |
| Target species | Human |
| For use with (application) | Colorimetric detection |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3630 |
| Gene symbol(s) | IDDM,IDDM1,IDDM2,ILPR,IRDN,MODY10 |
| Incubation time | 0.75 h |
| Coefficient of inter-dose variation | 8.5% |
| Coefficient of intra-dose variation | 5.4% |
| Contents of kits | 96-well pre-coated plate, Streptavidine HRP, Streptavidine HRP, Washing stamp, Washing stamp, Stop solution, Discontinuance solution |
| Marker or dye | HRP |
| Genetic marker | Insulin |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum (50 μl) |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 45 min |
Origin and customs
| Manufacturer ref. | KAQ1251 |
|---|
| Country of origin | United Kingdom |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.